Dakshidin Corporation (OTC:DKSC), a growing presence in the health and wellness sector, is proud to announce a significant advancement in its strategic roadmap.
The study showed that Telos95® halts the shortening of telomeres, decreases cellular age by an average of 7.43 years, and lengthens telomeres when used daily for just 6 months.
